Three Years of the Gefitinib UK Single Patient Access (SPA) Scheme: Duration of Treatment for Patients with EGFR Mutation Positive NSCLC in NHS Clinical Practice

✍ Scribed by Vioix, H.; Franzen, S.; Selby, D.; Collomb, D.; Hauch, O.; Emmas, C.

• Book ID: 122282273
• Publisher: John Wiley and Sons
• Year: 2013
• Tongue: English
• Weight: 58 KB
• Volume: 16
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2013.08.585